Home › Idiopathic Thrombocytopenic Purpura › Washington
Idiopathic Thrombocytopenic Purpura clinical trials in Washington
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Washington.
Cities in Washington
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- University of Washingto, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07104565A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- University of Washingto, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT07083960From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.